Jin-Qiu (Jessie) Chen

VP, Product Development @ OriGene

About

- Passionate about innovations in biomedicine and advanced technologies - 25+ years of advanced experience in therapeutic research, translational medicine, biomarker study and diagnostics development - Executive in product development and delivery, quality & risk management, strategic alliance, team growth and business development

Country

United States

City

Washington DC-Baltimore Area

Industry

Biotechnology

Skill

Experience

VP, Product Development

OriGene

2024-5 - Present · 2 yrs 5 mos

Rockville, Maryland, United States

VP, Product and Application Development

ACROBiosystems

2020-9 - 2024-5 · 3 yrs 9 mos

Develop strategies, build resources and lead cross-functional teams to increase ACROBiosystems’ portfolio and profile. As a global leader providing Top-Brand recombinant proteins, ACRO strives to offer high-performance critical reagents and bioassays to accelerate therapeutic development process. Through rapid product, technology and business model innovations, ACRO is dedicated to be a Partner-of-Choice in the global biomedicine and diagnostic industry.

Head, Collaborative Protein Technology Resource (CPTR)

Center for Cancer Research, National Cancer Institute, NIH

2012-2 - 2020-9 · 8 yrs 8 mos

Lead the CPTR/CCR/NCI program on developing and implementing state-of-the-art molecular-profiling technologies for functional-proteomic investigation, biomarker and therapeutic-target identification and validation as well as therapeutic-treatment assessment and application for precision medicine.

Senior Research Fellow, Antibody Product and Production Laboratory

National Cancer Institute (NCI)

2009-5 - 2012-1 · 2 yrs 9 mos

Collaborated with innovative technology vendors to develop and apply high-performance clinical-applicable proteomic assays for cell-signaling profiling, targeted- and combination-therapy assessment, as well as investigation of drug resistance

Senior Research Scientist / Group Lead

QPS

2007-10 - 2009-5 · 1 yr 8 mos

Principal Investigator in bio-analysis for pharmacokinetic, immunogenicity and toxicology studies in support of IND & NDA applications and clinical trials.